Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR TEST SYSTEMS CTO Donald P. Richmond II reported acquiring 1,064 common shares on October 1, 2026, through the company's Amended and Restated 2006 Employee Stock Purchase Plan at $6.6725 per share. On the same date, 76 shares were withheld to satisfy tax-withholding obligations upon vesting of restricted stock units, at a reported $101.6000 per share; the footnote says this does not represent a sale by the reporting person.
AEHR Test Systems Chief Operating Officer Adil Engineer acquired 730 common shares on October 1, 2026, through the company’s Amended and Restated 2006 Employee Stock Purchase Plan at $6.6725 per share. The plan is described as a tax-conditioned plan under Internal Revenue Code Section 423. On the same date, 98 shares were withheld to satisfy tax obligations upon vesting of restricted stock units; the footnote says this was not a sale. No Rule 10b5-1 plan is reported.
AEHR Test Systems CFO Chris Siu reported two transactions on October 1, 2026. A trust acquired 1,089 shares through the company’s Amended and Restated 2006 Employee Stock Purchase Plan at $6.6725 per share, with a reported trust holding of 6,795 shares afterward. Separately, 194 shares were withheld for tax obligations upon restricted stock unit vesting; this was not a sale. Siu’s reported direct holdings afterward were 77,134 shares, including shares subject to unvested restricted stock units. No Rule 10b5-1 plan is reported.
Aehr Test Systems (AEHR) is soliciting proxies for its 2026 annual meeting on October 19, 2026 at its Fremont, California headquarters. Holders of 32,659,546 shares of common stock as of August 27, 2026 may vote on electing six directors, ratifying BPM LLP as auditor for fiscal 2027, and approving an advisory say‑on‑pay resolution.
The board has an independent chairman, three key committees composed entirely of independent directors, and a Code of Conduct and Ethics. Outside directors receive role‑based cash retainers and annual RSU grants that vest quarterly, with stock ownership guidelines of at least one year of cash compensation. The proxy details an executive pay program emphasizing at‑risk bonuses and RSUs, change‑in‑control and severance agreements for the CEO and two other NEOs, a Dodd‑Frank compliant clawback policy, and the board’s oversight of cybersecurity risk, including regular Audit Committee briefings and an information security insurance policy.
AEHR TEST SYSTEMS (AEHR) reported that Executive VP of R&D Didier Wimmers had 317 shares of common stock withheld on September 3, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units, which the company notes does not represent a market sale. Following this tax-withholding disposition, Wimmers holds 12,379 shares directly, including shares underlying unvested restricted stock units, and no Rule 10b5-1 trading plan is reported.
AEHR TEST SYSTEMS (AEHR) reported an insider equity transaction by CFO Chris Siu. On 2026-09-01, 496 shares of common stock were withheld at $76.59 per share to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares; this was not an open-market sale. Following this tax-withholding disposition, Siu directly held 77,328 shares, including shares subject to unvested restricted stock units, and indirectly held 5,706 shares by trust.
AEHR TEST SYSTEMS (AEHR) reported that executive officer Vernon Rogers, Exec VP of Sales & Marketing, sold a total of 5,994 shares of common stock in open market or private transactions. The sales occurred on August 14, 2026 (two trades of 1,000 shares at $134.00 and $139.00) and on August 17, 2026 (3,994 shares at $143.77). A footnote explains that the amount reported for one transaction includes shares subject to unvested restricted stock units. The Rule 10b5-1 trading plan checkbox was not marked as applying to these transactions.
AEHR insider Vernon I. Rogers filed to potentially sell 3,994 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ, with an indicated aggregate value of $574,217.38 and an anticipated sale date of August 17, 2026. The disclosure also lists prior equity compensation events where restricted stock vested on multiple dates in 2025, and notes that 2,000 shares of common stock were sold on August 14, 2026 for $273,000.00.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a bona fide gift of 500 shares of Common Stock on 2026-08-14, donated to the Engineer Z&A Giving Fund. Following the donation, he holds 46,477 shares directly, which includes shares subject to unvested restricted stock units.